drugset / Trial / NCT07611344

The Effect of Remimazolam Versus Propofol on Postoperative Extubation Time

NCT07611344

Phase 4 Recruiting 82 enrolled Xuyu Zhang
RandomizedParallel-groupTriple-blindOther

Summary

This clinical trial aims to help us understand how two drugs, Propofol and Remazoloam, affect when researchers remove a Participants' breathing tube after liver surgery (laparoscopic liver resection).The main research questions include: comparing the time to breathing tube removal between patients who receive each drug, comparing changes in heart rate and blood pressure during surgery, and comparing the rates of unwanted medical events after surgery. Researchers will give either Propofol or Remimazolam as a sedative medicine for anesthesia. This will allow the researchers to compare the time to breathing tube removal after surgery. Participants will complete their surgery according to a pre-planned surgical plan.

Timeline

Start
2026-05-31
Primary completion
2026-12-01
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 4 mg/kg Intravenous
Comparator Propofol Small molecule 10 mg/kg Intravenous
Subject Remimazolam Small molecule 0.4 mg/kg Intravenous
Subject Remimazolam Small molecule 0.7 mg/kg Intravenous

Indications

No indication recorded.